These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24147514)

  • 1. How will the growing threat of resistant hypertension impact the future treatment of high blood pressure?
    Lackland DT
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1541-6. PubMed ID: 24147514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of new clinical trials on recent guidelines on hypertension management.
    Mancia G; Grassi G
    Ann Med; 2011 Mar; 43(2):124-32. PubMed ID: 21254905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the effectiveness of hypertension management be improved?
    Ruilope LM
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):689-95. PubMed ID: 23750678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice.
    Volpe M; Tocci G
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):811-20. PubMed ID: 20528639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR; Zappe D; Orloski LA; Sowers JR
    J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
    Basile J; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory hypertensive patients treated by cardiologists in France.
    Blacher J; Peroz-Froz J; Huberman JP; Ferrini M; Jullien G; Guenoun M; Guedj-Meynier D
    Arch Cardiovasc Dis; 2013 Feb; 106(2):86-92. PubMed ID: 23527912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
    Conlin PR
    Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of control of high blood pressure and treatment recommendations in Canada.
    Khan N; Chockalingam A; Campbell NR
    Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure management in hemodialysis: what have we learned?
    Peixoto AJ; Santos SF
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):561-6. PubMed ID: 20827194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a randomized study to determine the value of central Blood Pressure for GUIDing managEment of hypertension: the BP GUIDE study.
    Sharman JE; Marwick TH; Abhayaratna WP; Stowasser M
    Am Heart J; 2012 May; 163(5):761-7. PubMed ID: 22607852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for combination therapy in hypertension.
    Gradman AH
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):486-91. PubMed ID: 22871676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.